| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rein Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | 23 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | 23 Jul 2025 | 1 | $0 | 4 | Director | 23 Jul 2025, 19:42 |
| ALRN | Aileron Therapeutics, Inc. | 02 Dec 2024 | 1 | $0 | 4 | Director | 06 Dec 2024, 16:41 |
| ALRN | Aileron Therapeutics, Inc. | 20 Aug 2024 | 1 | $0 | 4 | Director | 22 Aug 2024, 16:09 |
| ALRN | AILERON THERAPEUTICS INC | 30 Mar 2022 | 1 | $0 | 4/A | President and Chief Executive Officer, Director | 30 Mar 2022, 20:33 |
| ALRN | AILERON THERAPEUTICS INC | 22 Mar 2022 | 1 | $0 | 4 | President and Chief Executive Officer, Director | 24 Mar 2022, 19:44 |
| ALRN | AILERON THERAPEUTICS INC | 15 Jun 2021 | 1 | $0 | 4 | President and Chief Executive Officer, Director | 17 Jun 2021, 19:56 |